Messe Frankfurt Germany, 5-7/11/2019 For the fifth consecutive year, IASIS PHARMA successfully participated as an exhibitor in CPhI Worldwide, the main international Trade Fair of the Pharmaceutical Industry sector. For 2019, CPhI was held in the exhibition center “Messe Frankfurt” in Germany, from November 5th to 7th. During the exhibition, numerous industry professionals visited our [...]
Ramada Plaza Thraki Hotel, Alexandroupoli, 10-13/10/2019 IASIS PHARMA participated in the 39th Panhellenic Gastroenterology Conference, organized by the Hellenic Society of Gastroenterology (E.G.E) at Ramada Plaza Thraki Hotel, Alexandroupoli, 10-13 October 2019. IASIS PHARMA presented Mastihatherapy® caps, the unique traditional herbal medicinal product, containing 350mg of pure Chios Mastic (Pistacia lentiscus var chia), recommended for the treatment [...]
Megaron Athens International Conference Centre Athens, 10-12/10/2019 The Hellenic Society for the Study of Bone Metabolism (HSSBM) and the Dutch Society for Calcium and Bone Metabolism (NVCB), successfully carried out a Joint Meeting in Megaron Athens International Conference Centre, from October 10th to October 12th 2019. IASIS PHARMA was actively present in the conference, proving [...]
Zappeion Mansion, Athens, 5-8/09/2019 During September 5th -8th, the Society for the Study of Dermatovenereologic and Allergic Diseases (S.S.D.A.D.) held the 2nd Panhellenic Conference at Zappeion Aegli, Athens, under the theme: “Dermatological diseases 2019: Past, present and future”. IASIS PHARMA was present, participating dynamically once more in the field of Dermatology. Dermatologists who attended the Conference had the chance [...]
Picture taken from the sanctification ceremony that took place in July 2019, marking the beginning of the construction of Chios Mastiha Research & Development Center. Click here to read a very interesting NY Times article about Chios Mastiha. Chios Mastiha Research & Development Center was established in Kallimassia, Chios in the summer of 2017, aiming to [...]
IASIS PHARMA proudly announces the addition of Glucofree® & Glucoplus® to its wide product portfolio. Glucofree® & Glucoplus® have metformin hydrochloride as their active ingredient and they belong to OHAs (Oral Hypoglycemic Agents). Metformin’s therapeutic indication is type 2 diabetes, especially on obese patients when the imposed diet and body exercise are not enough to [...]
Friendship club of Ampelokipi, Athens, 20-21/5/2019 Social Corporate Responsibility is one of IASIS PHARMA main operative principals. Supporting medical experts and patients, IASIS PHARMA cooperated for once more with the Greek association for skeletal health “Petalouda” (Petalouda stands for Butterfly in Greek) and carried out a large event for various skeletal problems and osteoporosis. The event took [...]
MAKEDONIA PALACE HOTEL, Thessaloniki, 18-20/4/2019 IASIS PHARMA participated in the 19th Panhellenic Conference for Hypertension. The event took place in 18-20 April 2019, at Makedonia Palace Hotel, Thessaloniki, under the auspices of the Greek Society of Hypertension (E.E.Y). At IASIS PHARMA stand, HCPs were informed about the range ofhigh quality pharmaceutical products that IASIS PHARMA offers in the CVP [...]
GRAND HYATT HOTEL Athens, 19 - 20/04/2019 IΑSIS PHARMA participated in the Annual Spring Day Conference of the Hellenic Society of Dermatology and Venereology, proving its dedication in the field of Dermatology. For 2019, the conference was held at Grand Hyatt Hotel Athens, between April 19th and 20th. At IASIS PHARMA exhibition stand, HCPs were introduced [...]
Royal Olympic Hotel Athens, 15-16/3/2019 IASIS PHARMA participated as a Gold Sponsor in the 24th Greek Conference for Helicobacter pylori and Other Infections of the Digestive Tract. The conference was organized by the Greek Society of Gastroenterology and the Hellenic Society for Infectious Diseases, at Royal Olympic Hotel Athens, 15-16 March 2019. IASIS PHARMA presented mastihatherapy® caps, [...]
